Free Shipping on purchases over €100

Klorane Serum Sos a la Peonía Bio 100 ml

Klorane Sos Peony Serum Bio 100 ml

El Sérum Sos a la peonía Bio fabricado por Klorane es un producto cosmético con ingredientes naturales que ayudan a calmar, proteger y relajar la zona del cuero cabelludo. Su uso no necesita aclarado y tampoco deja el pelo graso o apelmazado.

SKU: 181869
-23%
15% discount.
13.40
€17.40
€13.40
/100ml

Pharmaceutical Care

Safe medication sales

Secure shipping

INFO AND TECHNICAL SPECIFICATIONS

Sos a la peony Bio serum manufactured by Klorane is a cosmetic product designed to soothe scalp irritation and to help moisturise and balance the microbiome. Its formula is based on 97% natural ingredients, where the remaining 3% are excipients necessary for its stability.

The main active ingredient of the formula is peony extract of organic origin. It contains a high content of paeoniflorin, a key ingredient that brings soothing and anti-irritant properties to the composition.

The benefits of the product are based on 3 concepts: calm, protection and relaxation. The first is based on providing a soothing effect that helps to eliminate any discomfort or irritation immediately. The protection is due to the fact that, when applied to the scalp, the ingredients have a pH suitable for the area and are quickly assimilated by the area to prevent any future discomfort. The latter concept is thanks to the fact that it provides a soothing sensation that helps to eliminate any remaining itchiness or discomfort in the area.

In addition, its mild fragrance also promotes relaxation of the mind and mood.

Tecnical specifications card

Pharmaceutical advice

You can now consult our team with any questions you may have. We remind you that our chatbot is also available for simpler queries.

Ask us
  • Vendor: Laboratoires Pierre Fabre
  • Vendor address: 45 Place Abel Gance, 92100 Boulogne-Billancourt
  • Phone number: +33 5 63 58 88 00
Newsletter

Don’t miss anything

Stay up to date with the latest advances in health, discounts, and pharmaceutical news.